A Study to Evaluate the Efficacy and Safety of ASP4901 in Patients With Benign Prostate Hyperplasia

NCT02038868 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

320

Enrollment

INDUSTRY

Sponsor class

Conditions

Benign Prostate Hyperplasia

Interventions

DRUG: ASP4901
DRUG: Tamsulosin
DRUG: Placebo

Sponsor

Astellas Pharma Inc